Related references
Note: Only part of the references are listed.Rationally Designed ACE2-Derived Peptides Inhibit SARS-CoV-2
Ross C. Larue et al.
BIOCONJUGATE CHEMISTRY (2021)
Prospective mapping of viral mutations that escape antibodies used to treat COVID-19
Tyler N. Starr et al.
SCIENCE (2021)
Domains and Functions of Spike Protein in SARS-Cov-2 in the Context of Vaccine Design
Xuhua Xia
VIRUSES-BASEL (2021)
The variant gambit: COVID-19's next move
Jessica A. Plante et al.
CELL HOST & MICROBE (2021)
Kobophenol A Inhibits Binding of Host ACE2 Receptor with Spike RBD Domain of SARS-CoV-2, a Lead Compound for Blocking COVID-19
Suresh Gangadevi et al.
JOURNAL OF PHYSICAL CHEMISTRY LETTERS (2021)
SARS-CoV-2 and SARS-CoV Spike-Mediated Cell-Cell Fusion Differ in Their Requirements for Receptor Expression and Proteolytic Activation
Bojan F. Hoernich et al.
JOURNAL OF VIROLOGY (2021)
Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies
Rita E. Chen et al.
NATURE MEDICINE (2021)
Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera
Xuping Xie et al.
NATURE MEDICINE (2021)
Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape
Kevin R. McCarthy et al.
SCIENCE (2021)
Blockade of SARS-CoV-2 spike protein-mediated cell-cell fusion using COVID-19 convalescent plasma
Ling Wang et al.
SCIENTIFIC REPORTS (2021)
Gains from no real PAINS: Where 'Fair Trial Strategy' stands in the development of multi-target ligands
Jianbo Sun et al.
ACTA PHARMACEUTICA SINICA B (2021)
Evolution of assay interference concepts in drug discovery
Juergen Bajorath
EXPERT OPINION ON DRUG DISCOVERY (2021)
Toward an Understanding of Pan-Assay Interference Compounds and Promiscuity: A Structural Perspective on Binding Modes
Sarah Naomi Bolz et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2021)
Neutralising antibody escape of SARS-CoV-2 spike protein: Risk assessment for antibody-based Covid-19 therapeutics and vaccines
Daniele Focosi et al.
REVIEWS IN MEDICAL VIROLOGY (2021)
SARS-CoV-2 evolution and vaccines: cause for concern?
Thomas C. Williams et al.
LANCET RESPIRATORY MEDICINE (2021)
TMPRSS2 expression dictates the entry route used by SARS-CoV-2 to infect host cells
Jana Koch et al.
EMBO JOURNAL (2021)
Variants of SARS-CoV-2
Adam S. Lauring et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Rate and risk factors for breakthrough SARS-CoV-2 infection after vaccination
Adeel A. Butt et al.
JOURNAL OF INFECTION (2021)
Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization
Delphine Planas et al.
NATURE (2021)
How the Delta variant achieves its ultrafast spread
Sara Reardon
NATURE (2021)
Delta variant: What is happening with transmission, hospital admissions, and restrictions?
Elisabeth Mahase
BMJ-BRITISH MEDICAL JOURNAL (2021)
ACE2-Independent Interaction of SARS-CoV-2 Spike Protein with Human Epithelial Cells Is Inhibited by Unfractionated Heparin
Lynda J. Partridge et al.
CELLS (2021)
Severe SARS-CoV-2 Breakthrough Reinfection With Delta Variant After Recovery From Breakthrough Infection by Alpha Variant in a Fully Vaccinated Health Worker
Jayanthi Shastri et al.
FRONTIERS IN MEDICINE (2021)
Pan-coronavirus fusion inhibitors possess potent inhibitory activity against HIV-1, HIV-2, and simian immunodeficiency virus
Danwei Yu et al.
EMERGING MICROBES & INFECTIONS (2021)
Nuisance compounds in cellular assays
Jayme L. Dahlin et al.
CELL CHEMICAL BIOLOGY (2021)
Recent developments in pharmaceutical salts: FDA approvals from 2015 to 2019
Sonali S. Bharate
DRUG DISCOVERY TODAY (2021)
The emergence of vaccine hesitancy among upper-class Brazilians: Results from four birth cohorts, 1982-2015
Mariangela F. Silveira et al.
VACCINE (2020)
Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein
Shuai Xia et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
The Novel Coronavirus Originating in Wuhan, China Challenges for Global Health Governance
Alexandra L. Phelan et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses
Michael Letko et al.
NATURE MICROBIOLOGY (2020)
Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion
Shuai Xia et al.
CELL RESEARCH (2020)
Expression of SARS-CoV-2 receptor ACE2 and TMPRSS2 in human primary conjunctival and pterygium cell lines and in mouse cornea
Di Ma et al.
EYE (2020)
Cell entry mechanisms of SARS-CoV-2
Jian Shang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Immunogenicity of a DNA vaccine candidate for COVID-19
Trevor R. F. Smith et al.
NATURE COMMUNICATIONS (2020)
Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV
Xiuyuan Ou et al.
NATURE COMMUNICATIONS (2020)
Coronavirus membrane fusion mechanism offers a potential target for antiviral development
Tiffany Tang et al.
ANTIVIRAL RESEARCH (2020)
The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity
Qianqian Li et al.
CELL (2020)
Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses
Fabian Schmidt et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
High Potency of a Bivalent Human VH Domain in SARS-CoV-2 Animal Models
Wei Li et al.
CELL (2020)
De novo design of picomolar SARS-CoV-2 miniprotein inhibitors
Longxing Cao et al.
SCIENCE (2020)
Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor
Jinsung Yang et al.
NATURE COMMUNICATIONS (2020)
A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19
Xuping Xie et al.
NATURE COMMUNICATIONS (2020)
Computational Design of 25-mer Peptide Binders of SARS-CoV-2
Thassanai Sitthiyotha et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2020)
Stapled Peptides Based on Human Angiotensin-Converting Enzyme 2 (ACE2) Potently Inhibit SARS-CoV-2 Infection In Vitro
Francesca Curreli et al.
MBIO (2020)
Potential Simultaneous Inhibitors of Angiotensin-Converting Enzyme 2 and Transmembrane Protease, Serine 2
Ching-Yuan Wu et al.
FRONTIERS IN PHARMACOLOGY (2020)
De novo design of potent and resilient hACE2 decoys to neutralize SARS-CoV-2
Thomas W. Linsky et al.
SCIENCE (2020)
ACE2: Evidence of role as entry receptor for SARS-CoV-2 and implications in comorbidities
Natalia Zamorano Cuervo et al.
ELIFE (2020)
Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants
Yiska Weisblum et al.
ELIFE (2020)
Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2
Jianhui Nie et al.
EMERGING MICROBES & INFECTIONS (2020)
Mutations in the SARS-CoV-2 spike RBD are responsible for stronger ACE2 binding and poor anti-SARS-CoV mAbs cross-neutralization
Masaud Shah et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2020)
Computational advances in combating colloidal aggregation in drug discovery
Daniel Reker et al.
NATURE CHEMISTRY (2019)
Vaccine hesitancy: Not a new phenomenon, but a new threat
Mary Koslap-Petraco
JOURNAL OF THE AMERICAN ASSOCIATION OF NURSE PRACTITIONERS (2019)
Salts of Therapeutic Agents: Chemical, Physicochemical, and Biological Considerations
Deepak Gupta et al.
MOLECULES (2018)
Enterokinase Enhances Influenza A Virus Infection by Activating Trypsinogen in Human Cell Lines
Hideki Hayashi et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2018)
Machine Learning Distinguishes with High Accuracy between Pan-Assay Interference Compounds That Are Promiscuous or Represent Dark Chemical Matter
Swarit Jasial et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
The Ecstasy and Agony of Assay Interference Compounds
Courtney Aldrich et al.
ACS MEDICINAL CHEMISTRY LETTERS (2017)
Passive Transfer of A Germline-like Neutralizing Human Monoclonal Antibody Protects Transgenic Mice Against Lethal Middle East Respiratory Syndrome Coronavirus Infection
Anurodh Shankar Agrawal et al.
SCIENTIFIC REPORTS (2016)
Structure, Function, and Evolution of Coronavirus Spike Proteins
Fang Li
ANNUAL REVIEW OF VIROLOGY, VOL 3 (2016)
Role of Cytochrome P450 2C8 in Drug Metabolism and Interactions
Janne T. Backman et al.
PHARMACOLOGICAL REVIEWS (2016)
An analysis of the attrition of drug candidates from four major pharmaceutical companies
Michael J. Waring et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
Macropinocytosis Is the Entry Mechanism of Amphotropic Murine Leukemia Virus
Izabela Rasmussen et al.
JOURNAL OF VIROLOGY (2015)
A Conformation-Dependent Neutralizing Monoclonal Antibody Specifically Targeting Receptor-Binding Domain in Middle East Respiratory Syndrome Coronavirus Spike Protein
Lanying Du et al.
JOURNAL OF VIROLOGY (2014)
Chemical con artists foil drug discovery
Jonathan Baell et al.
NATURE (2014)
Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor
Lu Lu et al.
NATURE COMMUNICATIONS (2014)
Colloidal Aggregation Causes Inhibition of G Protein-Coupled Receptors
Maria F. Sassano et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Structure of the Fusion Core and Inhibition of Fusion by a Heptad Repeat Peptide Derived from the S Protein of Middle East Respiratory Syndrome Coronavirus
Jing Gao et al.
JOURNAL OF VIROLOGY (2013)
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
Ulrich M. Zanger et al.
PHARMACOLOGY & THERAPEUTICS (2013)
Coronaviruses as DNA Wannabes: A New Model for the Regulation of RNA Virus Replication Fidelity
Everett Clinton Smith et al.
PLOS PATHOGENS (2013)
Rhodanine as a scaffold in drug discovery: a critical review of its biological activities and mechanisms of target modulation
Tihomir Tomasic et al.
EXPERT OPINION ON DRUG DISCOVERY (2012)
Privileged Scaffolds or Promiscuous Binders: A Comparative Study on Rhodanines and Related Heterocycles in Medicinal Chemistry
Thomas Mendgen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel
Yong Zhang et al.
COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE (2010)
New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays
Jonathan B. Baell et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
The effect of plasma protein binding on in vivo efficacy: misconceptions in drug discovery
Dennis A. Smith et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Design, Synthesis, and Structure-Activity Relationship of a Novel Series of 2-Aryl 5-(4-Oxo-3-phenethyl-2-thioxothiazolidinylidenemethyl)furans as HIV-1 Entry Inhibitors
Alan R. Katritzky et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Characterization of chemical libraries for luciferase inhibitory activity
Douglas S. Auld et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Stoichiometry and physical chemistry of promiscuous aggregate-based inhibitors
Kristin E. D. Coan et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2008)
Conserved Salt Bridge between the N- and C-Terminal Heptad Repeat Regions of the Human Immunodeficiency Virus Type 1 gp41 Core Structure Is Critical for Virus Entry and Inhibition
Yuxian He et al.
JOURNAL OF VIROLOGY (2008)
Gains from the separation of conjoined twins
Jiaming Sun et al.
PLASTIC AND RECONSTRUCTIVE SURGERY (2008)
Resveratrol inhibits firefly luciferase
Adel Bakhtiarova et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Interpreting steep dose-response curves in early inhibitor discovery
Brian K. Shoichet
JOURNAL OF MEDICINAL CHEMISTRY (2006)
A detergent-based assay for the detection of promiscuous inhibitors
Brian Y. Feng et al.
NATURE PROTOCOLS (2006)
Central ions and lateral asparagine/glutamine zippers stabilize the post-fusion hairpin conformation of the SARS coronavirus spike glycoprotein
S Duquerroy et al.
VIROLOGY (2005)
Metabolism-based drug-drug interactions: What determines individual variability in cytochrome P450 induction?
C Tang et al.
DRUG METABOLISM AND DISPOSITION (2005)
Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors
SW Liu et al.
LANCET (2004)
Identification and prediction of promiscuous aggregating inhibitors among known drugs
J Seidler et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
A specific mechanism of nonspecific inhibition
SL McGovern et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Effect of detergent on promiscuous inhibitors
AJ Ryan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening
SL McGovern et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Evidence that the transition of HIV-1 gp41 into a six-helix bundle, not the bundle configuration, induces membrane fusion
GB Melikyan et al.
JOURNAL OF CELL BIOLOGY (2000)
Share Paper
